VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.596
+0.001 (0.18%)
At close: Mar 9, 2026, 4:00 PM EDT
0.590
-0.006 (-1.01%)
After-hours: Mar 9, 2026, 4:00 PM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $19.87 million as of March 9, 2026. Its market cap has decreased by -50.12% in one year.
Market Cap
19.87M
Enterprise Value
-9.68M
1-Year Change
-50.12%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $19.87M, a decrease of -91.35%. That is a compound annual growth rate of -33.54%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lixte Biotechnology Holdings | 21.26M |
| Polyrizon | 20.90M |
| Reviva Pharmaceuticals Holdings | 20.87M |
| NanoViricides | 20.72M |
| Lexaria Bioscience | 20.63M |
| Genenta Science | 20.15M |
| Intensity Therapeutics | 20.14M |
| Allarity Therapeutics | 19.94M |